These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8999759)

  • 1. [Antitubercular activity of lomefloxacin in an experiment].
    Mozhokina GN; Sokolova GB; Makarova OV; Mikhaĭlova LP
    Antibiot Khimioter; 1996; 41(7-8):31-3. PubMed ID: 8999759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis.
    JI B; Lounis N; Truffot-Pernot C; Grosset J
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1341-4. PubMed ID: 7574527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lomefloxacin in complex treatment of acute progressive form of pulmonary tuberculosis].
    Sokolova GB; Kunichan AD; Koriakin VA; Lazareva IaV
    Antibiot Khimioter; 1998; 43(10):10-2. PubMed ID: 9825102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of lomefloxacin on the functional activity of the phagocytic system].
    Mozhokina GN; Gracheva MP; Sokolova GB
    Antibiot Khimioter; 1996 Mar; 41(3):25-8. PubMed ID: 8967798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains].
    Mozhokina GN; Sokolova GB; Dashieva DG; Mikhaĭlova LP; Elistratova NA
    Probl Tuberk Bolezn Legk; 2005; (2):19-22. PubMed ID: 15881962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.
    Lounis N; Bentoucha A; Truffot-Pernot C; Ji B; O'Brien RJ; Vernon A; Roscigno G; Grosset J
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3482-6. PubMed ID: 11709328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of action of lomefloxacin on Mycobacterium tuberculosis].
    Mozhokina GN; Kunichan AD; Levchenko TN; Smirnova NS
    Antibiot Khimioter; 1998; 43(10):13-6. PubMed ID: 9825103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal inhibitory concentrations of lomefloxacin and minocycline against drug-sensitive and drug-resistant isolates of M. tuberculosis compared on L-J and 7H11 media.
    Kamala T; Herbert D; Venkatesan P; Paramasivan CN
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):375-8. PubMed ID: 9401493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Difluoroquinolone lomefloxacin (Maxaquin): its role among fluoroquinolones, possibilities and prospectives].
    Padeĭskaia EN
    Antibiot Khimioter; 1998; 43(10):4-9. PubMed ID: 9825101
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
    Piersimoni C; Morbiducci V; Bornigia S; De Sio G; Scalise G
    Am Rev Respir Dis; 1992 Dec; 146(6):1445-7. PubMed ID: 1333738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A broad-spectrum antimicrobial preparation--lomefloxacin (Maxaquin): the results of 10 years of its use in the clinics of Russia].
    Padeĭskaia EN
    Antibiot Khimioter; 2000; 45(1):39-44. PubMed ID: 10690427
    [No Abstract]   [Full Text] [Related]  

  • 13. [The chemotherapeutic efficacy of ciprofloxacin and lomefloxacin in the inhalation method of infecting white mice with tularemia].
    D'iakov SI; Bubnov VP; Lebedeva IK; Sidorenko SV; Moskalenko VI
    Antibiot Khimioter; 2000; 45(6):17-20. PubMed ID: 10904804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of maxaquin in the treatment of progressive pulmonary tuberculosis occurring with standard chemotherapy regimens].
    Mar'iandyshev AO; Klinberg NM; Shonbina AI; Moroz MI
    Probl Tuberk; 1997; (4):19-21. PubMed ID: 9333808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.
    Ji B; Lounis N; Maslo C; Truffot-Pernot C; Bonnafous P; Grosset J
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2066-9. PubMed ID: 9687408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
    Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lomefloxacin in phthisiatric practice].
    Grishin VK; Polunina TE
    Antibiot Khimioter; 1998; 43(10):17-8. PubMed ID: 9825104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Course of murine tuberculosis and response to first-line therapy depends on route of infection and inoculum size.
    de Steenwinkel JE; ten Kate MT; de Knegt GJ; Verbrugh HA; van Belkum A; Hernandez-Pando R; Bakker-Woudenberg IA
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1478-84, i. PubMed ID: 22008760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decreased resistance of multiresistant mycobacteria to isoniazid during the treatment of experimental tuberculosis with ozone and isoniazid].
    Belianin II
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):95-8. PubMed ID: 15346963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activities of newly developed quinolones, fleroxacin, lomefloxacin and sparfloxacin against Mycobacterium tuberculosis].
    Kawahara S; Kamisaka K; Tada A; Nakada H; Mishima Y; Yoshimoto S; Matsuyama T; Kibata M; Nagare J
    Kekkaku; 1991 Jun; 66(6):429-31. PubMed ID: 1942726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.